-+ 0.00%
-+ 0.00%
-+ 0.00%

Gene Biotech plans KRW 434,300,000 share buyback

PUBT·11/16/2026 12:17:39
Listen to the news
Gene Biotech plans KRW 434,300,000 share buyback
  • Gene Biotech plans to buy back 86,000 common shares for 434.3 million won.
  • Purchases will run from Nov. 17, 2026, through Feb. 16, 2027, on the Kosdaq market.
  • The buyback aims to fund employee performance compensation and stabilize the share price.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene Biotech Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261116001646), on November 16, 2026, and is solely responsible for the information contained therein.